Propyliodone

Propyliodone
Clinical data
Other names	propyl (3,5-diiodo-4-oxopyridin-1(4H)-yl)acetate
ATC code	V08AD03 (WHO) ;
Identifiers
	IUPAC name propyl 2-(3,5-diiodo-4-oxo-1,4-dihydropyridin-1-yl)acetate;
CAS Number	587-61-1 ;
PubChem CID	4949;
ChemSpider	4780 ;
UNII	5NPJ6BPX36;
ChEMBL	ChEMBL1200821 ;
CompTox Dashboard (EPA)	DTXSID6023527 ;
ECHA InfoCard	100.008.731
Chemical and physical data
Formula	C10H11I2NO3
Molar mass	447.011 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCCOC(=O)CN1C=C(C(=O)C(=C1)I)I;
	InChI InChI=1S/C10H11I2NO3/c1-2-3-16-9(14)6-13-4-7(11)10(15)8(12)5-13/h4-5H,2-3,6H2,1H3 ; Key:ROSXARVHJNYYDO-UHFFFAOYSA-N ;
	(what is this?) (verify)

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Propyliodone (INN, trade name Dionosil) is a molecule used as a contrast medium in bronchography.^[1] It was developed by a team at Imperial Chemical Industries^[2] in the late 1930s.

References

^ Pfeifer W, Seidel K (February 1958). "[Experiences with propyliodone bronchography]". Medizinische Klinik (in German). 53 (8): 293–5. PMID 13540854.
^ GB 517382

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

[pmid13540854-1] Pfeifer W, Seidel K (February 1958). "[Experiences with propyliodone bronchography]". Medizinische Klinik (in German). 53 (8): 293–5. PMID 13540854.

[2] GB 517382

[1]